| pubmed-article:7522874 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7522874 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7522874 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:7522874 | lifeskim:mentions | umls-concept:C0205851 | lld:lifeskim |
| pubmed-article:7522874 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:7522874 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:7522874 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:7522874 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7522874 | pubmed:dateCreated | 1994-11-1 | lld:pubmed |
| pubmed-article:7522874 | pubmed:abstractText | To examine the long-term survival of a group of patients with non-seminomatous germ cell tumours, who relapse after chemotherapy and are retreated with a cisplatin and etoposide-based regimen. | lld:pubmed |
| pubmed-article:7522874 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7522874 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7522874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7522874 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7522874 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:7522874 | pubmed:issn | 0007-1331 | lld:pubmed |
| pubmed-article:7522874 | pubmed:author | pubmed-author:BagshaweK DKD | lld:pubmed |
| pubmed-article:7522874 | pubmed:author | pubmed-author:NewlandsE SES | lld:pubmed |
| pubmed-article:7522874 | pubmed:author | pubmed-author:RustinG JGJ | lld:pubmed |
| pubmed-article:7522874 | pubmed:author | pubmed-author:BegentR HRH | lld:pubmed |
| pubmed-article:7522874 | pubmed:author | pubmed-author:BramptonMM | lld:pubmed |
| pubmed-article:7522874 | pubmed:author | pubmed-author:LedermannJ... | lld:pubmed |
| pubmed-article:7522874 | pubmed:author | pubmed-author:HolderHH | lld:pubmed |
| pubmed-article:7522874 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7522874 | pubmed:volume | 74 | lld:pubmed |
| pubmed-article:7522874 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7522874 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7522874 | pubmed:pagination | 225-30 | lld:pubmed |
| pubmed-article:7522874 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:meshHeading | pubmed-meshheading:7522874-... | lld:pubmed |
| pubmed-article:7522874 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7522874 | pubmed:articleTitle | The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours. | lld:pubmed |
| pubmed-article:7522874 | pubmed:affiliation | Department of Medical Oncology, Charing Cross Hospital, London, UK. | lld:pubmed |
| pubmed-article:7522874 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7522874 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7522874 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7522874 | lld:pubmed |
